Grant for Early-Stage Alzheimer's Therapeutics Research Funding in New York (USA)
GrantID: 68778
Grant Funding Amount Low: $1
Deadline: Ongoing
Grant Amount High: $2,000,000
Summary
The grant program is offering a targeted challenge funding program for early phase human trials of potential therapies targeting Alzheimer's disease and related dementias. Both small for-profit and non-profit businesses are eligible for the program, and foreign candidates must provide proof of their yearly profits and net assets. Applications are accepted from organizations undertaking studies all over the world, with full-time staff or academic positions preferred...
Eligible Regions
Interests
Eligible Requirements
Grant Detailed Description
View Full Grant Details
Additional Criteria of Eligibility
Additional Funding in Information
Estimated Size of Grant
Contact Info
Funding Source
Overview
This grant is meant to financially support organizations or entities that focus their efforts on, but not limited to: Business & Commerce, Health & Medical, Higher Education, Non-Profit Support Services, Research & Evaluation, Science, Technology Research & Development, Small Business in New York (USA).